CVS Health Corp (NYSE: CVS) is -1.98% lower on its value in year-to-date trading and has touched a low of $64.41 and a high of $83.25 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CVS stock was last observed hovering at around $76.42 in the last trading session, with the day’s gains setting it 0.98%.
Currently trading at $77.40, the stock is 2.41% and 2.04% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 17.12 million and changing 1.28% at the moment leaves the stock 7.35% off its SMA200. CVS registered 2.65% gain for a year compared to 6-month gain of 10.65%. The firm has a 50-day simple moving average (SMA 50) of $0.46 and a 200-day simple moving average (SMA200) of $9.09.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 1.30% loss in the last 1 month and extending the period to 3 months gives it a 2.80%, and is 3.10% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.31% over the week and 1.96% over the month.
CVS Health Corp (CVS) has around 300000 employees, a market worth around $97.40B and $358.27B in sales. Current P/E ratio is 11.97 and Fwd P/E is 8.39. Profit margin for the company is 2.33%. Distance from 52-week low is 20.17% and -7.03% from its 52-week high. The company has generated returns on investments over the last 12 months (5.52%).
CVS Health Corp quarterly earnings per share for the current quarter are estimated at $1.71 with sales reaching $89.25B over the same period.The EPS is expected to shrink by -5.05% this year, but quarterly earnings will post 3.60% year-over-year. Quarterly sales are estimated to grow 10.40% in year-over-year returns.
CVS Health Corp (CVS) Top Institutional Holders
2,805 institutions hold shares in CVS Health Corp (CVS), with institutional investors hold 83.22% of the company’s shares. The shares outstanding are 1.29B, and float is at 1.26B with Short Float at 1.92%. Institutions hold 83.10% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 116.68 million shares valued at $8.07 billion. The investor’s holdings represent 9.08% of the CVS Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 93.73 million shares valued at $6.48 billion to account for 7.30% of the shares outstanding. The other top investors are State Street Corporation which holds 55.88 million shares representing 4.35% and valued at over $3.86 billion, while Morgan Stanley holds 2.59% of the shares totaling 33.25 million with a market value of $2.3 billion.
CVS Health Corp (CVS) Insider Activity
The most recent transaction is an insider sale by Shah Prem S,the company’sEVP and Pres-Pharm, Consumer W. SEC filings show that Shah Prem S sold 29,473 shares of the company’s common stock on Feb 16 ’24 at a price of $76.95 per share for a total of $2.27 million. Following the sale, the insider now owns 39765.0 shares.
CVS Health Corp disclosed in a document filed with the SEC on Nov 03 ’23 that LUDWIG EDWARD J (Director) bought a total of 2,000 shares of the company’s common stock. The trade occurred on Nov 03 ’23 and was made at $70.47 per share for $0.14 million. Following the transaction, the insider now directly holds 20630.0 shares of the CVS stock.
Still, SEC filings show that on Aug 03 ’23, Clark James David (SVP, Cont & Chief Acct Officer) disposed off 25,759 shares at an average price of $74.92 for $1.93 million. The insider now directly holds 4,698 shares of CVS Health Corp (CVS).
